Friday, December 12, 2008 10:16:57 PM
Wednesday November 5, 2008.
BRIDGEWATER, N.J. (AP) -- Synchronoss Technologies Inc., a transaction management software supplier for communications companies, said third-quarter profit fell more than 70 percent on declining revenue related to major customer AT&T Inc.
The company's earnings dropped sharply to $2.3 million, or 7 cents per share, from $8 million, or 24 cents per share, in the same quarter last year. Revenue fell to $26.3 million from $34.5 million.
Excluding one-time items, the company said it would have earned 11 cents per share, compared with 26 cents in the same quarter last year.
Analysts polled by Thomson Reuters expected 10 cents, on average, and revenue of $26.8 million. Analysts typically exclude one-time charges and gains.
Synchronoss said business related to Dallas-based AT&T, the exclusive U.S. carrier of Apple Inc.'s iPhone, represented 66 percent of revenue in the third quarter, down from 67 percent in the second quarter and 78 percent in the year-ago quarter.
Shares fell 65 cents, or 7.9 percent, to close at $7.61.
Recent SNCR News
- Synchronoss Technologies Announces First Quarter 2024 Earnings Call Date and Participation in Upcoming Investor Events • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Synchronoss Technologies Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 01:23:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 01:15:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 01:03:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:46:59 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:26:39 PM
- Synchronoss Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, March 12, 2024 at 4:30 p.m. ET • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:18:37 PM
- Synchronoss to Unveil New Version of AI-Powered Personal Cloud Platform at Mobile World Congress • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:28:23 PM
- Synchronoss Successfully Completes Post-Divestiture Cost Removals, Resulting in Approximately $15 Million in Annual Savings • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/12/2024 02:06:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/12/2024 02:04:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 01:34:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:35:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 01:46:15 PM
- Synchronoss Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 12/28/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:18:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 01:29:34 PM
- Synchronoss Completes Cloud-Only Transformation, Reaffirms 2023 and 2024 Financial Projections • GlobeNewswire Inc. • 12/11/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 01:26:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 10:30:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 10:30:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM